Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parth A Desai

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Lung Cancer|February 20, 2026
When Timing is Everything: Rethinking Immunotherapy Integration With Definitive ChemoradiationParth A Desai, Martin J Edelman
AIDS (London, England)|August 19, 2016
Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignanciesVictor E Mulanovich, Parth A Desai, Uday R Popat
Journal of Clinical and Diagnostic Research : JCDR|March 5, 2015
Intracranial Fungal Granulomas Mimicking High Grade Gliomas. A Decisive Role of Squash Cytology (SC): A Report of Two CasesParth A Desai, Ronak K Patel, Nita Khurana, et al.
The American Journal of Surgical Pathology|October 9, 2015
High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor PrognosisShaoying Li, Vivian L Weiss, Xuan J Wang, et al.
Nature Communications|September 1, 2025
Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinomaBinbin Wang, Robert Saddawi-Konefka, Lauren M Clubb, et al.
Clinical Epidemiology|December 26, 2025
A Multi-Country Study of the Clinical Course of Extensive-Stage Small Cell Lung Cancer: A Six-Study Analysis of Real-World Treatment Patterns and OutcomesXerxes Pundole, Diana Younan, Cathy W Critchlow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 5, 2017
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphomaAndrés E Quesada, L Jeffrey Medeiros, Parth A Desai, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Lung Cancer|February 20, 2026
When Timing is Everything: Rethinking Immunotherapy Integration With Definitive ChemoradiationParth A Desai, Martin J Edelman
AIDS (London, England)|August 19, 2016
Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignanciesVictor E Mulanovich, Parth A Desai, Uday R Popat
Journal of Clinical and Diagnostic Research : JCDR|March 5, 2015
Intracranial Fungal Granulomas Mimicking High Grade Gliomas. A Decisive Role of Squash Cytology (SC): A Report of Two CasesParth A Desai, Ronak K Patel, Nita Khurana, et al.
The American Journal of Surgical Pathology|October 9, 2015
High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor PrognosisShaoying Li, Vivian L Weiss, Xuan J Wang, et al.
Nature Communications|September 1, 2025
Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinomaBinbin Wang, Robert Saddawi-Konefka, Lauren M Clubb, et al.
Clinical Epidemiology|December 26, 2025
A Multi-Country Study of the Clinical Course of Extensive-Stage Small Cell Lung Cancer: A Six-Study Analysis of Real-World Treatment Patterns and OutcomesXerxes Pundole, Diana Younan, Cathy W Critchlow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 5, 2017
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphomaAndrés E Quesada, L Jeffrey Medeiros, Parth A Desai, et al.
Pageof 1